Ccdc92
≈ 2 min read
Names in other languages
- DeutschCcdc92
- EnglishCcdc92
- EspañolCcdc92
- FrançaisCcdc92
- NederlandsCcdc92
- PortuguêsCcdc92
- srnCcdc92
- SvenskaCcdc92
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
CCDC92, or Limkain beta-2, is a protein which in humans is encoded by the CCDC92 gene. It is likely involved in DNA repair or reduction/oxidation reactions. The gene ubiquitously found in humans and is highly conserved across animals. The CCDC92 gene is located at cytogenic location 12q24.31 and is 36,576 bases long with nine exons which codes for a 331 amino-acid long protein.
CCDC92, or Limkain beta-2, is a protein which in humans is encoded by the CCDC92 gene. It is likely involved in DNA repair or reduction/oxidation reactions. The gene ubiquitously found in humans and is highly conserved across animals. The CCDC92 gene is located at cytogenic location 12q24.31 and is 36,576 bases long with nine exons which codes for a 331 amino-acid long protein.
Clinical significance
In large B-cell Lymphona Lines, CCDC92 expression is increased in the presence of a histone deacetylase inhibitor (Panobinostat) or a hypomethylating agent (Decitabine). It is further increased when these two drugs are combined and increase expression by up to 10 percentiles. In leukemia cell line, CCDC92 expression is also increased in the presence of a tyrosine-kinase inhibitor, Imantinib These two changes could be significant if CCDC92 is involved in repairing damaged oncogenes. If that was the case, any of the pharmaceuticals which increased CCDC92 expression could be used to introduce more of it into the body to find damaged DNA sequences and repair them.
References
Text derived from https://en.wikipedia.org/w/index.php?oldid=1374574340 under CC BY-SA 4.0; modifications have been made.